Sinco Pharmaceuticals Holdings Ltd operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sinco Pharmaceuticals Holdings Ltd with three other
drug stores in Asia:
China Resources Phoenix Healthcare Holdings Company Ltd
sales of 1.88 billion Chinese Renmimbi [US$270.77 million]
of which 46%
was GPO business),
Amway (Malaysia) Holdings Berhad
(984.21 million Malaysian Ringgits [US$239.81 million]
of which 100%
was Distribution of Prod), and
GuangYuYuan Chinese Herbal Medicine Co Ltd
based in China
(1.17 billion Chinese Renmimbi [US$168.36 million]
of which 93%
was Drug Industry).
Sinco Pharmaceuticals Holdings Ltd reported sales of HK$1.74 billion (US$221.71 million)
December of 2017.
increase of 73.7%
versus 2016, when the company's sales were HK$1.00 billion.